Yaojun Zhang

33PUBLICATIONS
79CO-AUTHORS
HaematologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Jun 01, 2026
HAIC Combined with Lenvatinib and Pembrolizumab for Unresectable Hepatocellular Carcinoma: A Retrospective Study.

|Dec 08, 2025
HBV Reactivation in Patients with Hepatocellular Carcinoma Treated with PD-1/-L1 Antibodies and Concurrent Antiviral Prophylaxis Agents: A Prospective Observational Study.

Zefeng Du, Zhicheng Lai, Yexing Huang

|Oct 27, 2025
Immunotherapy-Based Strategies versus Transcatheter Arterial Chemoembolization and the Impact of Treatment Duration in Hepatocellular Carcinoma with Microvascular Invasion: A Retrospective Multicenter Cohort Study.

Xiaokun Chen, Jiali Xing, Baoluhe Zhang

|Aug 11, 2025
Social Support, Quality of Life, and Financial Toxicity Among Patients with Hepatocellular Carcinoma.

Shuyue Liu, Yawen Xie, Tiantian Li

|Mar 25, 2025
Reply to: Importance of Defining Recurrence in Hepatocellular Carcinoma: Local or Both Local and Other Intrahepatic Recurrences?

Mian Xi, Yizhen Fu, Yaojun Zhang

|Mar 24, 2025
Combined TACE with Targeted and Immunotherapy versus TACE Alone Improves DFS in HCC with MVI: A Multicenter Propensity Score Matching Study.

Xiaokun Chen, Xiangan Wu, Wei Peng

Pageof 6

Frequent Collaborators

16 joint publications

Jinbin Chen

13 joint publications

Yangxun Pan

13 joint publications

Li Xu

10 joint publications

Yizhen Fu